Osteochondral Lesions of the Talus


There is no cost to participate in this online course. The estimated time to complete this course is 30 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

You must log in or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.

Target Audience

Foot and ankle providers (DPM, DO, MD, NP, PA, PT).

Educational Need

Osteochondral lesions of the talus (OLTs) are a difficult pathologic entity to treat. Lesion size, location, chronicity, and characteristics such as displacement and subchondral cysts help dictate the appropriate treatment required to achieve a satisfactory result. In general, operative treatment is reserved for patients with displaced OLTs or those who have failed nonoperative treatment for 3 to 6 months. Operative treatments can be broken down into cartilage repair, replacement, and regenerative strategies. There are many promising treatment options, and research is needed to elucidate which are superior to minimizing the morbidity from OLTs.


  • Diagnosis of osteochondral lesion of the talus.
  • List two surgical techniques for bone marrow stimulation surgery for treating osteochondral lesions of the talus.
  • Review post-operative recovery protocol.


Sean T. Grambart, DPM, FACFAS
Assistant Professor, College of Podiatric Medicine and Surgery, Des Moines University
Past President, American College of Foot and Ankle Surgeons

Dr. Grambart joined the Des Moines University Foot and Ankle Clinic and College of Podiatric Medicine and Surgery in the Fall 2019 after practicing with the Urbana, IL-based Carle Physician Group and Carle Foundation Hospital’s surgery department since 2004.

He is a Diplomat and board-certified physician in foot surgery and ankle/rearfoot surgery by the American Board of Foot and Ankle Surgery. He also is a past president and current Fellow of the American College of Foot and Ankle Surgeons.

A frequent presenter at podiatric medical conferences with numerous published articles and textbook chapters, Dr. Grambart, completed a surgical residency with the Northwest Podiatric Surgical Program at the Swedish Medical Center-Providence campus in Seattle and a trauma and reconstruction fellowship in Dresden, Germany. He was the 2014 CPMS Alumnus of the Year.

Full biography.

Relevant to the content of this educational activity, Dr. Grambart indicates he is on the design team for Orthosolutions. Dr. Grambart does not intend to discuss off-label uses of a commercial product(s)/device(s).

Terms of Use and Privacy Policy

Date of original release: March 31, 2020
Most recent review/update: March 31, 2020
Termination date: March 30, 2023

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AOA Category 1­B
  • 0.50 CE Contact Hour(s)
  • 0.50 CPME
Course opens: 
Course expires: 

Accreditation Statements

  • DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 0.5 continuing education contact hours.
  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.5 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 


The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.


The information provided in this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AOA Category 1­B
  • 0.50 CE Contact Hour(s)
  • 0.50 CPME


Please login or Create an Account to take this course.